223 related articles for article (PubMed ID: 19885783)
1. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Türkbey B; Thomasson D; Pang Y; Bernardo M; Choyke PL
Diagn Interv Radiol; 2010 Sep; 16(3):186-92. PubMed ID: 19885783
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging in oncology.
Knopp MV; Giesel FL; Marcos H; von Tengg-Kobligk H; Choyke P
Top Magn Reson Imaging; 2001 Aug; 12(4):301-8. PubMed ID: 11687716
[TBL] [Abstract][Full Text] [Related]
3. Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
Paldino MJ; Barboriak DP
Magn Reson Imaging Clin N Am; 2009 May; 17(2):277-89. PubMed ID: 19406359
[TBL] [Abstract][Full Text] [Related]
4. Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
Yan Y; Sun X; Shen B
Oncotarget; 2017 Jun; 8(26):43491-43505. PubMed ID: 28415647
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of tumor microcirculation: promise for the new millennium.
Taylor JS; Tofts PS; Port R; Evelhoch JL; Knopp M; Reddick WE; Runge VM; Mayr N
J Magn Reson Imaging; 1999 Dec; 10(6):903-7. PubMed ID: 10581502
[TBL] [Abstract][Full Text] [Related]
6. Technical and practical considerations for permeability modeling of dynamic contrast enhanced MRI.
Roberts T
Acad Radiol; 2005 May; 12 Suppl 1():S34-7. PubMed ID: 16106544
[No Abstract] [Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
9. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer.
Tuncbilek N; Kaplan M; Altaner S; Atakan IH; Süt N; Inci O; Demir MK
AJR Am J Roentgenol; 2009 Apr; 192(4):949-55. PubMed ID: 19304699
[TBL] [Abstract][Full Text] [Related]
10. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.
Ferl GZ; Port RE
Clin Pharmacol Ther; 2012 Jul; 92(1):118-24. PubMed ID: 22588603
[TBL] [Abstract][Full Text] [Related]
11. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.
Verma S; Turkbey B; Muradyan N; Rajesh A; Cornud F; Haider MA; Choyke PL; Harisinghani M
AJR Am J Roentgenol; 2012 Jun; 198(6):1277-88. PubMed ID: 22623539
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.
Hassanien OA; Abouelkheir RT; Abou El-Ghar MI; Badawy ME; El Gamal SA; El-Hamid MA
Can Assoc Radiol J; 2019 Aug; 70(3):254-263. PubMed ID: 30922786
[TBL] [Abstract][Full Text] [Related]
13. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.
Wang B; Gao ZQ; Yan X
Acta Radiol; 2005 Jul; 46(4):353-8. PubMed ID: 16134309
[TBL] [Abstract][Full Text] [Related]
14. Imaging of angiogenesis: clinical techniques and novel imaging methods.
Provenzale JM
AJR Am J Roentgenol; 2007 Jan; 188(1):11-23. PubMed ID: 17179341
[TBL] [Abstract][Full Text] [Related]
15. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI for oncology drug development.
Sung YS; Park B; Choi Y; Lim HS; Woo DC; Kim KW; Kim JK
J Magn Reson Imaging; 2016 Aug; 44(2):251-64. PubMed ID: 26854494
[TBL] [Abstract][Full Text] [Related]
17. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
18. Assessing tumor angiogenesis using macromolecular MR imaging contrast media.
Brasch R; Pham C; Shames D; Roberts T; van Dijke K; van Bruggen N; Mann J; Ostrowitzki S; Melnyk O
J Magn Reson Imaging; 1997; 7(1):68-74. PubMed ID: 9039595
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
Calcagno C; Mani V; Ramachandran S; Fayad ZA
Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
[TBL] [Abstract][Full Text] [Related]
20. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
